IPP Bureau
Alembic Pharmaceuticals Q3 FY23 revenue up 19% to Rs. 1,509 Cr
By IPP Bureau - February 07, 2023
Net sales for 9M FY23 up 9% to Rs. 4,246 crore and net profit for 9M FY23 at Rs. 189 crore
Vidya Balan launches cancer prevention initiative SEEDS
By IPP Bureau - February 07, 2023
SEEDS is a mnemonic for Shun Tobacco, Eat Correctly, Exercise Regularly, Dump obesity and excess alcohol, and Stay vigilant about your family history aims at making more and more people aware about the tenets of cancer prevention
Need a paradigm shift for popularising ayurveda in India
By IPP Bureau - February 07, 2023
For discovery or for standardization, Ayurveda colleges/institutes need to collaborate closely with Phytochemists, Pharmacologists, and Toxicologists from premier institutions
Bal Pharma posts Q3 FY2023 profit at Rs. 59.16 lakhs
By IPP Bureau - February 07, 2023
The company has reported total income of Rs.77.0791 crores during the period ended December 31, 2022 as compared to Rs.69.9191 crores during the period ended December 31, 2021.
ART and Surrogacy Bill strives to provide patients with better medical care and security: Dr. Mandaviya
By IPP Bureau - February 06, 2023
With the on-going relentless efforts to imbibe new developments in ART, India will make significant progress in ensuring the best facilities and care for fertility to couples in India
Umesh Kunte appointed CEO of Albert David
By IPP Bureau - February 06, 2023
A pharma industry veteran with over three decades of experience in domestic as well as international markets
.jpg "Emcure organizes awareness drive on World Cancer Day")
Emcure organizes awareness drive on World Cancer Day
By IPP Bureau - February 06, 2023
The company is proud to be at the forefront of promoting cancer awareness and hopes to make a positive impact on the lives of its employees
Janssen and Eli Lilly collaboration to address lack of pediatric therapies could rescue mirikizumab program, says GlobalData
By IPP Bureau - February 06, 2023
The agreement between Eli Lilly and Janssen was established to allow the two companies to share resources for the goal of accelerating the evaluation of the respective companies’ assets, mirikizumab and Tremfya (guselkumab).
Ruby Hall Clinic encourages people to take preventive tests for cancer
By IPP Bureau - February 06, 2023
On the day dedicated to the battle against the deadly disease – took to reaching the public of Pune to understand that cancer can be prevented and even reversed with the help of adequate testing
Krsnaa Diagnostics completes Tripura project
By IPP Bureau - February 04, 2023
Company has provided Image Transmission and Reporting of Radiology Images and Selective Radiology Services (X-ray Tele Radiology Services) across all districts in the state of Tripura during the month of June, 2022 and operationalized its services at all the allocated places as on date.
Ritesh Jain appointed CFO of Krebs Biochemicals and Industries
By IPP Bureau - February 04, 2023
He is a Chartered Accountant with more than 19 years of extensive experience
.jpg "Lupin launches Aptivate Champion Run for Kids")
Lupin launches Aptivate Champion Run for Kids
By IPP Bureau - February 04, 2023
Through this important initiative, Lupin Life encourages children from Mumbai, Thane, and Navi Mumbai to participate in the Aptivate Champion Run
AstraZeneca India expands ‘Ganga Godavari Cancer Screening’ initiative
By IPP Bureau - February 04, 2023
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Mumbai FC Football players encourage cancer survivors at Nanavati Max Super Speciality Hospital
By IPP Bureau - February 04, 2023
The players and management of Mumbai City FC presented patients with exclusive gifts, symbolizing support and appreciation for their fight against cancer
GMM Pfaudler posts Q3 FY23 consolidated profit at Rs. 18.67 Cr
By IPP Bureau - February 03, 2023
The company has reported total income of Rs. 781.40 crores during the period ended December 31, 2022
